遠隔患者モニタリングの世界市場-2024～2031年

概要

遠隔患者モニタリングの世界市場は2023年に502億米ドルに達し、2031年には2,510億米ドルに達すると予測され、予測期間2024～2031年のCAGRは22.4%で成長します。

遠隔患者モニタリングとは、デジタル技術、医療機器、通信システムを利用して、自宅や地域など従来の臨床環境以外で患者の健康をモニタリング・管理することを指します。遠隔患者モニタリングでは、バイタルサイン、症状、慢性的な状態に関連する患者のデータを継続的または定期的に収集し、それを医療プロバイダーに送信して、レビュー、分析、フォローアップケアを行う。モニタリング機器によって収集されたデータは、安全な無線通信技術を経由して医療プロバイダーやモニタリングプラットフォームに送信されます。データには、心拍数、血圧、血糖値、酸素飽和度などの指標が含まれます。

遠隔患者モニタリングの需要は、効率的な慢性疾患管理の必要性、より患者中心のケアモデルへの世界のシフト、遠隔患者モニタリングの採用の高まりにより、急速に伸びています。例えば、米国内の医療提供者を対象としたVivalink社の調査結果によると、回答者全体の84%が現在遠隔患者モニタリングを使用しており、2024年にはさらに使用を増やす予定であることが明らかになっています。また、Medscapeによると、2024年には米国で6,000万人以上が遠隔患者モニタリングを使用すると推定されています。

市場力学：

促進要因と抑制要因

慢性疾患の有病率の上昇

慢性疾患の増加は遠隔患者モニタリング市場の成長を大きく後押ししており、予測期間中も市場を牽引していくと予想されます。慢性疾患は、血圧、血糖値、心拍数、酸素飽和度などの主要なバイタルサインの定期的なモニタリングを必要とすることが多いです。遠隔患者モニタリングソリューションにより、患者は自宅で継続的に健康状態を追跡し、継続的な評価のために医療プロバイダーにデータを送信することができます。

例えば、国際糖尿病連合（IDF）によれば、世界中で4億6,300万人以上の成人が糖尿病を患っており、持続グルコースモニタリング（CGM）装置の需要は急増しています。DexcomやAbbottといった企業は、Dexcom G6やFreestyle Libreといった製品を発表しており、これらはグルコースレベルの遠隔モニタリングに広く使われています。これらのシステムは、患者がリアルタイムのグルコース測定値を受け取り、医療プロバイダーとデータを共有することで、より効果的な糖尿病管理を可能にします。

汎米保健機構（Pan American Health Organization）によると、高血圧は世界の成人人口の30％以上、世界中で10億人以上が罹患しています。オムロンの血圧計のような機器により、血圧を遠隔でモニタリングすることがますます一般的になってきています。遠隔患者モニタリングソリューションは、継続的な追跡を可能にし、患者や医療提供者がより効果的に病気を管理し、脳卒中や心不全などの合併症を回避するのに役立ちます。

CDCによると、心血管疾患は世界の主要死因であり、33秒に1人が心血管疾患で死亡しています。2022年には70万2,880人が心臓病で死亡します。これは死亡者5人に1人に相当します。遠隔患者モニタリングメドトロニックのMiniMedインスリンポンプやiRhythmのZio Patchのような連続心電図モニタリング用デバイスは、重要な指標を追跡し、必要なときに早期介入を確実にすることで、病院への受診を減らすのに役立ちます。

患者の受容と関与の欠如

遠隔患者モニタリング市場の成長にとって、患者の受容と関与の欠如が大きな障壁となっています。遠隔患者モニタリングは慢性疾患管理の改善や医療コストの削減など多くのメリットを提供しますが、多くの患者はまだこれらの技術を完全に受け入れることに苦労しています。この問題に関する主要課題には、技術的な障壁、理解や認識の不足、プライバシーに関する懸念などがあり、これらはすべて患者の導入やエンゲージメントに影響を与えます。

多くの患者、特に高齢者は、遠隔患者モニタリングデバイスや健康プラットフォームを使いにくいと感じています。これらの技術には一定レベルのデジタルリテラシーが要求されることが多く、デジタルツールに不慣れな人にとっては、セットアップのプロセスや継続的な使用方法が複雑に感じられたり、フラストレーションを感じたりすることがあります。

例えば、遠隔健康モニタリングは普及しつつあるが、遠隔患者モニタリングにとって重要な層である高齢の患者は、新しい技術を採用するのに苦労する可能性があります。特に心臓病や糖尿病のような慢性疾患の管理においては、高齢者の快適さや技術的な慣れのなさが普及の妨げとなっています。

患者は、データのプライバシーやセキュリティに対する懸念から、遠隔患者モニタリングソリューションの採用をためらうかもしれません。インターネットを介した機密性の高い健康データの伝送は、データ漏洩、個人健康情報への不正アクセスや悪用に関する問題を引き起こします。このような懸念は信頼を損ない、患者が遠隔患者モニタリング技術を十分に利用することを妨げる可能性があります。

例えば、HIPAAジャーナルによると、2023年8月には2,300万件の医療記録の漏洩が注目されています。過去12ヶ月間、毎月平均998万9,003件の医療記録が漏洩しています。2024年8月31日までの1年間で、500レコード以上のデータ漏洩が491件発生し、少なくとも5,866万8,002レコードが漏洩したことが判明しています。2024年の平均情報漏洩件数は11万9,487件、中央値は4,109件です。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 患者の受け入れと関与の欠如
    • 臓器移植の増加
  • 抑制要因
    • 患者の受け入れと関与の欠如
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 タイプ別

• ウェアラブルデバイス
  • スマートウォッチとフィットネストラッカー
  • スマートな服
  • ウェアラブル心電図モニター
  • パッチ
  • その他
• 非ウェアラブルデバイス
  • 血圧モニター
  • 血糖値モニタリング装置
  • 心電図モニター
  • パルスオキシメーター
  • 温度計
  • その他
• ソフトウェアサービス

第7章 技術別

• ウェアラブル技術
• BluetoothとWi-Fi技術
• 人工知能（AI）
• モバイルヘルス（mヘルス）
• その他

第8章 用途別

• 慢性疾患管理
• 術後ケア
• 母体の健康
• メンタルヘルス
• 緊急ケア
• 全般的健康とウェルネス
• その他

第9章 エンドユーザー別

• 病院
• 専門クリニック
• 在宅医療
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他の南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他のアジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Apple Inc.
• Koninklijke Philips N.V.
• Samsung SDS America, Inc.
• Humworld Inc.
• Medtronic plc
• Siemens Healthineers AG
• GE HealthCare
• Fitbit（Google）
• Abbott Laboratories
• Qardio, Inc.

第13章 付録

Overview

The global remote patient monitoring market reached US$ 50.2 billion in 2023 and is expected to reach US$ 251.0 billion by 2031, growing at a CAGR of 22.4% during the forecast period 2024-2031.

Remote patient monitoring refers to the use of digital technologies, medical devices and telecommunication systems to monitor and manage a patient's health outside of traditional clinical settings, such as at home or in a community setting. Remote patient monitoring involves the continuous or periodic collection of patient data related to vital signs, symptoms or chronic conditions, which is then transmitted to healthcare providers for review, analysis, and follow-up care. The data collected by the monitoring devices is transmitted via secure, wireless communication technologies to healthcare providers or monitoring platforms. The data can include metrics like heart rate, blood pressure, blood glucose levels, oxygen saturation and more.

The demand for remote patient monitoring is rapidly growing, driven by the need for efficient chronic disease management, the global shift toward more patient-centric care models and the rising adoption of remote patient monitoring. For instance, results of a Vivalink survey of providers across the U.S. revealed that 84% of the total respondents currently using remote patient monitoring and also plan to increase their usage in 2024. Additionally, according to Medscape, it is estimated that more than 60 million people in the U.S. will have used remote patient monitoring in 2024.

Market Dynamics: Drivers & Restraints

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases is significantly driving the growth of the remote patient monitoring market and is expected to drive the market over the forecast period. Chronic diseases often require regular monitoring of key vital signs, such as blood pressure, blood glucose levels, heart rate and oxygen saturation. Remote patient monitoring solutions enable patients to continuously track their health at home and transmit the data to healthcare providers for ongoing assessment.

For instance, with over 463 million adults worldwide living with diabetes, according to the International Diabetes Federation (IDF), the demand for continuous glucose monitoring (CGM) devices is soaring. Companies like Dexcom and Abbott have introduced products such as the Dexcom G6 and the Freestyle Libre, which are widely used for remote monitoring of glucose levels. These systems allow patients to receive real-time glucose readings and share data with healthcare providers, enabling more effective diabetes management.

According to the Pan American Health Organization, hypertension affects more than 30% of the adult population worldwide, more than one billion people around the world. Monitoring blood pressure remotely has become increasingly common with devices like Omron's Blood Pressure Monitor. Remote patient monitoring solutions allow for continuous tracking, which helps patients and providers manage the disease more effectively, avoiding complications like stroke or heart failure.

Cardiovascular diseases are the leading cause of death globally, according to the CDC, one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. Remote patient monitoring devices such as Medtronic's MiniMed insulin pumps and iRhythm's Zio Patch for continuous ECG monitoring help reduce hospital visits by tracking critical metrics and ensuring early intervention when needed.

Lack of patient acceptance and engagement

The lack of patient acceptance and engagement is a significant barrier to the growth of the remote patient monitoring market. While remote patient monitoring offers numerous benefits, such as improved chronic disease management and reduced healthcare costs, many patients still struggle to fully embrace these technologies. The key challenges related to this issue include technological barriers, lack of understanding or awareness and privacy concerns, all of which impact patient adoption and engagement.

Many patients, particularly older adults, find remote patient monitoring devices and health platforms difficult to use. These technologies often require a certain level of digital literacy, and for those who are not familiar with digital tools, the setup process or ongoing usage may seem complex or frustrating.

For instance, while remote health monitoring is gaining traction, older patients, who are a key demographic for remote patient monitoring, may struggle with adopting new technologies. This lack of comfort and technological familiarity among seniors hampers the widespread adoption, especially for managing chronic conditions like heart disease and diabetes.

Patients may be hesitant to adopt remote patient monitoring solutions due to concerns about data privacy and security. The transmission of sensitive health data over the internet raises issues related to data breaches, unauthorized access or misuse of personal health information. These concerns can undermine trust and discourage patients from fully engaging with remote patient monitoring technologies.

For instance, according to the HIPAA Journal, in August 2023, 23 million breached healthcare records are noticed. Over the past 12 months, an average of 9,989,003 healthcare records were breached each month. In the year to August 31, 2024, there have been 491 data breaches of 500 or more records, and at least 58,668,002 records are known to have been breached. The average breach size in 2024 is currently 119,487 records and the median breach size is 4,109 records.

Segment Analysis

The global remote patient monitoring market is segmented based on type, technology, application, end-user and region.

Type:

Wearable devices segment is expected to dominate the remote patient monitoring market share

The wearable devices segment is expected to dominate the global remote patient monitoring market due to their convenience, real-time data collection and continuous monitoring capabilities. Wearable devices are often the most user-friendly remote patient monitoring solutions, enabling patients to manage their health proactively while providing healthcare providers with consistent data for timely intervention.

Wearable devices are typically non-intrusive and easy to use, which makes them highly accessible to a wide range of patients. They allow for continuous monitoring of vital signs, such as heart rate, blood pressure, blood oxygen levels, and physical activity without the need for frequent hospital visits. For instance, Fitbit and Apple Watch are two widely used wearable devices that continuously track heart rate, steps and sleep patterns. These devices are designed to be worn throughout the day, giving users consistent feedback on their health while being minimally disruptive to their daily routine.

Wearables also help patients track their health, which motivates them to engage with their treatment plans. These devices often provide users with feedback, reminders and goals, fostering better self-management of chronic conditions and encouraging healthier behaviors. Thus, the market players are focusing on the development of remote patient monitoring devices with enhanced features.

For instance, in July 2024, Georgia-based KORE and Australian company mCare Digital launched a smartwatch for virtual patient monitoring called mCareWatch 241. The watch features an SOS setting that enables wearers to obtain emergency assistance, call capabilities, GPS tracking, reminders, a heart rate monitor, speed dialing, fall detection, a pedometer, a geo-fence alarm, non-movement detection and a mobile app and web dashboard.

Geographical Analysis

North America is expected to hold a significant position in the remote patient monitoring market share

North America is expected to hold the largest market share in the global remote patient monitoring market. North America, especially the United States, has a significant burden of chronic diseases such as diabetes, hypertension, heart disease and obesity, which drives the demand for remote monitoring solutions.

For instance, according to the CDC, an estimated 129 million people in the US have at least 1 major chronic disease (e.g., heart disease, cancer, diabetes, obesity, hypertension) as defined by the US Department of Health and Human Services. Remote patient monitoring helps manage these conditions by providing continuous monitoring, reducing hospital visits and enabling early interventions.

North America is a leader in digital health innovation, with widespread adoption of wearable devices, telehealth platforms and smart health technologies. This creates a favorable environment for remote patient monitoring solutions to thrive, as patients are increasingly willing to use technology to manage their health. For instance, the Apple Watch and Fitbit have become mainstream devices in North America, with features like heart rate monitoring, ECG and sleep tracking that are often used in conjunction with remote patient monitoring applications.

Asia-Pacific is growing at the fastest pace in the remote patient monitoring market

The Asia-Pacific region is experiencing the fastest growth in the remote patient monitoring market, owing to the strong presence of market players and innovative product launches, technological advancements and rising chronic disease prevalence. Asia Pacific especially India, Japan and China witnessed rapid growth in smartphone adoption, which has created a favorable environment for the use of wearables and mobile health applications. These technologies allow manufacturers to develop innovative wearable devices for remote patient monitoring.

For instance, Mindray launched the mWear system, an all-new wearable patient monitoring solution that enables an efficient workflow to continually monitor patient conditions and deliver advanced patient-centric care. mWearTM supports comprehensive and precise measurements of vital signs including ECG, oxygen saturation, noninvasive blood pressure, respiration rate, pulse rate and temperature.

Competitive Landscape

The major global players in the remote patient monitoring market include Apple Inc., Koninklijke Philips N.V., Samsung SDS America, Inc., Humworld Inc., Medtronic plc, Siemens Healthineers AG, GE HealthCare, Fitbit (Google), Abbott Laboratories, Qardio, Inc. and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global remote patient monitoring market report delivers a detailed analysis with 70 key tables, more than 69 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Type
• 3.2. Snippet by Technology
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Lack of Patient Acceptance and Engagement
    • 4.1.1.2. Increasing number of organ transplants
  • 4.1.2. Restraints
    • 4.1.2.1. Lack of Patient Acceptance and Engagement
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 6.1.2. Market Attractiveness Index, By Type
• 6.2. Wearable Devices*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.2.3. Smartwatches and Fitness Trackers
  • 6.2.4. Smart Clothing
  • 6.2.5. Wearable ECG Monitors
  • 6.2.6. Patches
  • 6.2.7. Others
• 6.3. Non-Wearable Devices
  • 6.3.1. Blood Pressure Monitors
  • 6.3.2. Glucose Monitoring Devices
  • 6.3.3. ECG Monitors
  • 6.3.4. Pulse Oximeters
  • 6.3.5. Thermometers
  • 6.3.6. Others
• 6.4. Software Services

7. By Technology

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 7.1.2. Market Attractiveness Index, By Technology
• 7.2. Wearable Technology*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Bluetooth and Wi-Fi Technology
• 7.4. Artificial Intelligence (AI)
• 7.5. Mobile Health (mHealth)
• 7.6. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Chronic Disease Management*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Post-Operative Care
• 8.4. Maternal Health
• 8.5. Mental Health
• 8.6. Emergency Care
• 8.7. General Health and Wellness
• 8.8. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Specialty Clinics
• 9.4. Homecare Settings
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Apple Inc.*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Koninklijke Philips N.V.
• 12.3. Samsung SDS America, Inc.
• 12.4. Humworld Inc.
• 12.5. Medtronic plc
• 12.6. Siemens Healthineers AG
• 12.7. GE HealthCare
• 12.8. Fitbit (Google)
• 12.9. Abbott Laboratories
• 12.10. Qardio, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us